Fasenra Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

fasenra

astrazeneca limited - benralizumab 30 mg/ml - solution for injection - 30 mg/ml - active: benralizumab 30 mg/ml excipient: histidine histidine hydrochloride monohydrate polysorbate 20 trehalose water for injection - fasenra is indicated as add-on therapy in patients aged 12 years and over with severe eosinophilic asthma (blood eosinophil count nlt 300 cells/µl or nlt 150 cells/µl if on oral corticosteroid treatment).

Fasenra Pen Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

fasenra pen

astrazeneca limited - benralizumab 30 mg/ml - solution for injection - 30 mg/ml - active: benralizumab 30 mg/ml excipient: histidine histidine hydrochloride polysorbate 20 trehalose water for injection - fasenra is indicated as add-on therapy in patients aged 12 years and over with severe eosinophilic asthma (blood eosinophil count nlt 300 cells/µl or nlt 150 cells/µl if on oral corticosteroid treatment).

FASENRA SOLUTION FOR INJECTION 30MGML (AUTOINJECTOR PEN) Սինգապուր - անգլերեն - HSA (Health Sciences Authority)

fasenra solution for injection 30mgml (autoinjector pen)

astrazeneca singapore pte ltd - benralizumab - injection, solution - benralizumab 30 mg / ml

Fasenra solution for injection 30 MG/1 ML Հորդանան - անգլերեն - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

fasenra solution for injection 30 mg/1 ml

مستودع ادوية شاوي و رشيدات و مسنات - shawi & rushedat drug store - benralizumab 30 mg/1 ml - 30 mg/1 ml